---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-017799"
form_type: "8-K"
ticker: "CODX"
cik: "0001692415"
company_name: "Co-Diagnostics, Inc."
filed_at: "2023-05-16T23:59:59+00:00"
generated_at: "2026-06-14T23:49:52.790657+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Co-Diagnostics adopts change-in-control severance plan; CEO 3x, CFO 2x multipliers

## Summary
- Board approved Change in Control Severance Plan for select management; CEO Dwight Egan gets 3x multiplier, CFO Brian Brown gets 2x.
- Severance benefit = multiplier times (base salary + greater of target bonus or avg of three highest actual bonuses).
- Benefits triggered by termination without cause or for good reason within 2 years after a change in control.
- Payment is lump sum after signing separation agreement; subject to Section 409A limitations.

## SEC filing metadata
- accession: 0001493152-23-017799
- form_type: 8-K
- ticker: CODX
- cik: 0001692415
- company_name: Co-Diagnostics, Inc.
- filed_at: 2023-05-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1692415/000149315223017799/0001493152-23-017799-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1692415/000149315223017799/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-017799
- JSON: https://secwatch.observer/filing/0001493152-23-017799.json
- Plain text: https://secwatch.observer/filing/0001493152-23-017799.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.